Compare Stocks: PAVM, APYX, ECOR, and KEQU

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.95	$3.39	$1.70 ▼ $5.08	$124.27M	1.31	126,138 shs	86,064 shs
ECOR electroCore	$11.42 -7.1%	$8.75	$4.41 ▼ $12.70	$110.81M	1	81,972 shs	113,311 shs
KEQU Kewaunee Scientific	$34.03 -0.2%	$36.38	$32.00 ▼ $46.57	$98.73M	0.73	4,104 shs	15,343 shs
PAVM PAVmed	$3.99 -4.5%	$4.89	$3.70 ▼ $28.44	$33.44M	0.53	25,071 shs	2,708 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-1.99%	-4.22%	-29.26%	+41.15%
ECOR electroCore	-7.08%	+7.23%	+18.34%	+58.83%	+120.89%
KEQU Kewaunee Scientific	-0.21%	-4.28%	-8.64%	-3.13%	-21.73%
PAVM PAVmed	-4.55%	+1.79%	-21.76%	-8.28%	-69.28%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.95	$3.39	$1.70 ▼ $5.08	$124.27M	1.31	126,138 shs	86,064 shs
ECOR electroCore	$11.42 -7.1%	$8.75	$4.41 ▼ $12.70	$110.81M	1	81,972 shs	113,311 shs
KEQU Kewaunee Scientific	$34.03 -0.2%	$36.38	$32.00 ▼ $46.57	$98.73M	0.73	4,104 shs	15,343 shs
PAVM PAVmed	$3.99 -4.5%	$4.89	$3.70 ▼ $28.44	$33.44M	0.53	25,071 shs	2,708 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-1.99%	-4.22%	-29.26%	+41.15%
ECOR electroCore	-7.08%	+7.23%	+18.34%	+58.83%	+120.89%
KEQU Kewaunee Scientific	-0.21%	-4.28%	-8.64%	-3.13%	-21.73%
PAVM PAVmed	-4.55%	+1.79%	-21.76%	-8.28%	-69.28%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.71	Moderate Buy	$6.60	123.73% Upside
ECOR electroCore	2.00	Hold	$18.00	57.62% Upside
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
PAVM PAVmed	2.00	Hold	$56.00	1,303.51% Upside

Current Analyst Ratings Breakdown

Latest PAVM, APYX, ECOR, and KEQU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	APYX Apyx Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/21/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/14/2026	PAVM PAVmed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (E+)
7/17/2026	PAVM PAVmed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
7/14/2026	APYX Apyx Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/13/2026	APYX Apyx Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00
6/30/2026	KEQU Kewaunee Scientific	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
6/24/2026	APYX Apyx Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/24/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$58.42M	2.13	N/A	N/A	$0.39 per share	7.56
ECOR electroCore	$36.97M	2.79	N/A	N/A	($0.21) per share	-54.38
KEQU Kewaunee Scientific	$282M	0.35	$5.94 per share	5.73	$26.67 per share	1.28
PAVM PAVmed	$70K	456.00	N/A	N/A	($2.42) per share	-1.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$11.21M	-$0.20	N/A	N/A	N/A	-14.78%	-76.60%	-13.91%	11/5/2026 (Estimated)
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	-1,956.38%	-81.35%	11/4/2026 (Estimated)
KEQU Kewaunee Scientific	$9.62M	$2.76	12.33	N/A	N/A	2.97%	11.61%	4.82%	N/A
PAVM PAVmed	$400K	-$16.05	N/A	N/A	N/A	-10,794.64%	-126.43%	-25.49%	11/12/2026 (Estimated)

Latest PAVM, APYX, ECOR, and KEQU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q1 2027	KEQU Kewaunee Scientific	N/A	$0.58	N/A	$0.58	N/A	$66.32 million
8/6/2026	Q2 2026	APYX Apyx Medical	-$0.0820	-$0.07	+$0.0120	-$0.07	$13.18 million	$13.88 million
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	3.19	5.68	4.53
ECOR electroCore	N/A	1.21	1.00
KEQU Kewaunee Scientific	0.51	2.20	1.57
PAVM PAVmed	0.98	1.19	1.19

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
ECOR electroCore	26.74%
KEQU Kewaunee Scientific	32.69%
PAVM PAVmed	19.93%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.90%
ECOR electroCore	7.80%
KEQU Kewaunee Scientific	14.10%
PAVM PAVmed	13.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	205	42.12 million	35.43 million	Optionable
ECOR electroCore	83	9.02 million	8.31 million	Not Optionable
KEQU Kewaunee Scientific	1,231	2.90 million	2.49 million	Not Optionable
PAVM PAVmed	41	8.00 million	6.93 million	No Data

PAVM, APYX, ECOR, and KEQU Headlines

Recent News About These Companies

Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways

September 22 at 7:55 AM | prnewswire.com

PAVmed Launches New At-the-Market Equity Offering

September 10, 2026 | tipranks.com

PAVmed (PAVM) Q2 2026 Earnings Call Transcript

August 14, 2026 | finance.yahoo.com

PAVmed Inc. Q2 2026 Earnings Call Summary

August 14, 2026 | finance.yahoo.com

PAVmed targets early 2027 Veris 510(k) submission while pursuing PortIO 510(k) pathway

August 14, 2026 | seekingalpha.com

PAVmed Inc. (PAVM) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

August 14, 2026 | prnewswire.com

PAVmed (PAVM) Releases Q2 2026 Earnings: Revenue Miss and Continued Losses

August 13, 2026 | quiverquant.comQ

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

August 13, 2026 | prnewswire.com

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

August 5, 2026 | prnewswire.com

Lucid Diagnostics to Participate in Upcoming Investor Conferences

August 4, 2026 | prnewswire.com

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

July 31, 2026 | prnewswire.com

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

July 30, 2026 | prnewswire.com

PAVmed Shareholders Approve Plan Changes at Annual Meeting

June 24, 2026 | tipranks.com

How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target

June 1, 2026 | finance.yahoo.com

PAVmed Inc. (NASDAQ:PAVM) Q1 2026 Earnings Call Transcript

May 16, 2026 | insidermonkey.com

PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...

May 15, 2026 | finance.yahoo.com

PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

May 15, 2026 | finanznachrichten.de

PAVmed (PAVM) Q4 2025 Earnings Transcript

May 15, 2026 | finance.yahoo.com

PAVmed targets Varis FDA submission by end of 2026 while evaluating new assets following cap table cleanup

May 15, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PAVM, APYX, ECOR, and KEQU Company Descriptions

Apyx Medical NASDAQ:APYX

$2.95 0.00 (0.00%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$2.95 +0.00 (+0.03%)

As of 07:35 AM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

electroCore NASDAQ:ECOR

$11.42 -0.87 (-7.08%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$11.60 +0.18 (+1.53%)

As of 04:02 AM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Kewaunee Scientific NASDAQ:KEQU

$34.03 -0.07 (-0.21%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$34.03 +0.00 (+0.01%)

As of 04:02 AM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

PAVmed NASDAQ:PAVM

$3.99 -0.19 (-4.55%)

Closing price 09/23/2026 03:59 PM Eastern

Extended Trading

$4.05 +0.06 (+1.60%)

As of 09/23/2026 07:00 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PAVM, APYX, ECOR, and KEQU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PAVM, APYX, ECOR, and KEQU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PAVM, APYX, ECOR, and KEQU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PAVM, APYX, ECOR, and KEQU Company Descriptions

Apyx Medical NASDAQ:APYX

electroCore NASDAQ:ECOR

Kewaunee Scientific NASDAQ:KEQU

PAVmed NASDAQ:PAVM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PAVM, APYX, ECOR, and KEQU Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PAVM, APYX, ECOR, and KEQU Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PAVM, APYX, ECOR, and KEQU Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PAVM, APYX, ECOR, and KEQU Company Descriptions

Apyx Medical NASDAQ:APYX

electroCore NASDAQ:ECOR

Kewaunee Scientific NASDAQ:KEQU

PAVmed NASDAQ:PAVM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools